Journal article Open Access

Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders

Scuderi, Caterina; De Filippis, Daniele; Filippis, Daniele De; Iuvone, Teresa; Blasio, Angelo; Steardo, Antonio; Esposito, Giuseppe

Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties. However, it is well established that CBD produces its biological effects without exerting significant intrinsic activity upon cannabinoid receptors. For this reason, CBD lacks the unwanted psychotropic effects characteristic of marijuana derivatives, so representing one of the bioactive constituents of Cannabis saliva with the highest potential for therapeutic use. The present review reports the pharmacological profile of CBD and summarizes results from preclinical and clinical studies utilizing CBD, alone or in combination with other phytocannabinoids, for the treatment of a number of CNS disorders. Copyright (C) 2008 John Wiley & Sons, Ltd.

Files (91.9 kB)
Name Size
article.pdf
md5:b91af6603af1eca0a21772c189871fc6
91.9 kB Download
343
220
views
downloads
Views 343
Downloads 220
Data volume 20.2 MB
Unique views 329
Unique downloads 202

Share

Cite as